Chen Feng, Liu Ke, Huang Qi-Hong, Liu Zhi-Wei, Cao Su-Mei
Department of Epidemiology, Clinical Trial Study Center, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Feb;46(2):125-8.
To explore the incidence regularity in populations with different fluctuation modes of Epstein-Barr virus (EBV) antibody levels.
Based on the data of a NPC mass screening for nasopharyngeal carcinoma (NPC) in Jianggu town and Didou town of Sihui city, Guangdong province from 1992 to 1998, 586 subjects who were positive and retested for twice or above were divided into ascending group (114 subjects), stable or fluctuating group (313 subjects), and descending group (159 subjects) according to the fluctuation of immunoglobulin A antibody against EBV capsid antigen (VCA-IgA) level; 9889 subjects who were negative in the first test of VCA-IgA were set as control group. All the participants were followed-up till December 31, 2007. The incidence, onset time and clinical characteristics of NPC were compared among groups.
The 5-year cumulative detection rates of ascending, stable or fluctuating, and descending group were 3.51% (4/114), 0.64% (2/313) and 0.00% (0/159), respectively; the 5-year cumulative detection proportions were 4/4, 2/6 and 0/2, respectively. Comparing to the control group, the hazard ratio (HR) for the incidence of NPC in ascending group was highest (HR = 10.96, 95%CI: 3.91 - 30.74), followed by stable or fluctuating group (HR = 5.79, 95%CI: 2.45 - 13.69), and descending group (HR = 3.84, 95%CI: 0.92 - 16.01) which had the lowest HR.
Individuals with stable, fluctuating or ascending VCA-IgA level showed higher risk and earlier onset of NPC was found in ascending group.
探讨不同EB病毒(EBV)抗体水平波动模式人群的发病规律。
基于1992年至1998年广东省四会市江谷镇和地豆镇鼻咽癌(NPC)大规模筛查数据,将586例EB病毒衣壳抗原免疫球蛋白A抗体(VCA-IgA)水平呈阳性且复查两次及以上的受试者,根据VCA-IgA水平波动情况分为上升组(114例)、稳定或波动组(313例)和下降组(159例);将9889例VCA-IgA首次检测为阴性的受试者设为对照组。所有参与者随访至2007年12月31日。比较各组NPC的发病率、发病时间及临床特征。
上升组、稳定或波动组、下降组的5年累积检出率分别为3.51%(4/114)、0.64%(2/313)和0.00%(0/159);5年累积检出比例分别为4/4、2/6和0/2。与对照组相比,上升组NPC发病的风险比(HR)最高(HR = 10.96,95%CI:3.91 - 30.74),其次是稳定或波动组(HR = 5.79,95%CI:2.45 - 13.69),下降组最低(HR = 3.84,95%CI:0.92 - 16.01)。
VCA-IgA水平稳定、波动或上升的个体显示出较高的风险,上升组NPC发病较早。